Literature DB >> 32776128

Changes in Cytomegalovirus Seroprevalence Among U.S. Children Aged 1-5 Years: The National Health and Nutrition Examination Surveys.

Molly R Petersen1, Eshan U Patel1,2, Alison G Abraham2,3, Thomas C Quinn4,5, Aaron A R Tobian1.   

Abstract

Data from the cross-sectional National Health and Nutrition Examination Surveys (NHANES) indicate that the seroprevalence of cytomegalovirus immunoglobulin G (IgG) antibodies among US children aged 1-5 years was 20.7% (95% confidence interval [CI]: 14.0, 29.0) in 2011-2012 and 28.2% (95% CI: 23.1-34.0) in 2017-2018 (adjusted prevalence difference, +7.6% [95% CI: -.4, +15.6]).
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CMV; NHANES; childhood vaccination; cytomegalovirus

Mesh：

Substances：

Year:  2021        PMID： 32776128      PMCID： PMC8248283          DOI： 10.1093/cid/ciaa1168

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  7 in total

1.  Prevention of mother-to-child transmission of viral infections.

Authors:  Jennifer S Read; Michael J Cannon; Lawrence R Stanberry; Susan Schuval
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008-10

2.  Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.

Authors:  Gayle S Bieler; G Gordon Brown; Rick L Williams; Donna J Brogan
Journal:  Am J Epidemiol       Date:  2010-02-04       Impact factor: 4.897

3.  Seroprevalence of cytomegalovirus among children 1 to 5 years of age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012.

Authors:  Tatiana M Lanzieri; Deanna Kruszon-Moran; Minal M Amin; Stephanie R Bialek; Michael J Cannon; Margaret D Carroll; Sheila C Dollard
Journal:  Clin Vaccine Immunol       Date:  2014-12-17

Review 4.  Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Authors:  Michael J Cannon; Terri B Hyde; D Scott Schmid
Journal:  Rev Med Virol       Date:  2011-06-15       Impact factor: 6.989

5.  Congenital cytomegalovirus (CMV) epidemiology and awareness.

Authors:  Michael J Cannon
Journal:  J Clin Virol       Date:  2009-10-02       Impact factor: 3.168

Review 6.  The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination.

Authors:  Paul Griffiths
Journal:  Antiviral Res       Date:  2020-02-17       Impact factor: 5.970

7.  Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.

Authors:  Amanda M Simanek; Jennifer Beam Dowd; Graham Pawelec; David Melzer; Ambarish Dutta; Allison E Aiello
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240
  7 in total
  3 in total

1.  Cytomegalovirus Seroprevalence Among US Children Aged 1 to 5 Years: The National Health and Nutrition Examination Surveys, 2017-March 2020 Pre-Pandemic Dataset.

Authors:  Tatiana M Lanzieri; Deanna Kruszon-Moran; Sheila C Dollard
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

Review 2.  Cytomegalovirus infection in liver-transplanted children.

Authors:  Norrapat Onpoaree; Anapat Sanpavat; Palittiya Sintusek
Journal:  World J Hepatol       Date:  2022-02-27

3.  A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.

Authors:  Witold Lewandowski; Carla Talarico; Karen Fowler; Jacek Mucha; Monika Neumann; Magdalena Kaczanowska; Maciej Grys; Elvira Schmidt; Andrew Natenshon; Philip O Buck; John Diaz-Decaro
Journal:  BMC Public Health       Date:  2022-09-01       Impact factor: 4.135
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.